The peptide synthesis market has gained major traction in recent years due to the wide applications of peptides in pharmaceutical development and research. Peptides are short chains of amino acids that can regulate numerous biological processes in humans. The peptide synthesis process involves the step-by-step fabrication of custom peptides as per research needs through chemical or enzymatic reactions. Peptides find applications as therapeutic drugs, diagnostics, vaccine development, and other biomedical applications. Technological advancements in peptide synthesis equipment and growing outsourcing of peptide production work to specialized contract manufacturing organizations are supporting the growth of the peptide synthesis industry.
The Global peptide synthesis market is estimated to be valued at US$ 490.58 Mn in 2024 and is expected to exhibit a CAGR of 7.4% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the peptide synthesis market are GenScript Biotech Corporation, Merck KGaA, ThermoFisher Scientific Inc., Syngene, Lonza, Novo Nordisk A/S, Bachem Holding AG, Gyros Protein Technologies, Creative Diagnostics, CEM Corporation, PuroSynth. These players are focusing on capacity expansion and new product launches to strengthen their market presence.
There is a huge opportunity for developing novel peptide-based drugs for the treatment of chronic diseases like cancer, diabetes, and cardiovascular diseases. Many biopharma companies are actively investing Peptide Synthesis Market Trends discovery and development. Growing outsourcing of custom peptide synthesis jobs to contract manufacturing organizations is opening new revenue streams for market players.
The global expansion of major peptide synthesis companies through partnerships, acquisitions, and direct investments in emerging markets will help penetrate untapped opportunities. Asia Pacific and Middle East regions are witnessing major investments by key players to manufacture peptides for clinical research and commercial applications.
Market drivers
The major market driver is the wide applications of peptides in the pharmaceutical industry for developing novel drugs and diagnostics. Peptides have certain advantages over small molecule drugs such as high selectivity and potency. Moreover, the increasing incidence of chronic diseases worldwide is propelling pharmaceutical and biotech companies to focus on peptide-based therapeutics development. Growing R&D expenditure on proteomics and genomic research involving peptide synthesis techniques is another key factor supporting the market growth.
PEST Analysis
Political: The regulation policies of government regarding R&D activities and funding are expected to have a positive impact on the Peptide Synthesis Market Size And Trends Various government initiatives are promoting the growth of pharmaceutical and biotechnology sectors.
Economic: The increasing healthcare expenditure globally and availability of funding for research activities are the major macroeconomic factors augmenting the market growth. The rising disposable income is also driving the demand for advanced treatment options.
Social: Growing awareness about healthcare and rising prevalence of chronic diseases such as cancer, metabolic disorders are fueling the demand for peptide drugs and therapeutics. Advancements in proteomics and genomics are further supporting research activities in this field.
Technological: Adoption of innovative techniques like microarray peptide synthesis and high throughput peptide synthesis is accelerating the research process. Automation and use of robotics in synthesis is improving productivity and minimizing production costs.
The peptide synthesis market in terms of value is concentrated majorly in North America and Europe. North America alone holds around 40% of the global market share due to presence of advanced research infrastructure and major players in the US and Canada.
The Asia Pacific region is considered as the fastest growing market for peptide synthesis.This is attributed to increasing investments by market players, rapid economic development, growing biologics industry and rising focus on healthcare by governments in emerging countries like India and China. The governments are focusing on developing local manufacturing capabilities to reduce dependency on other regions.
Comments
0 comment